Allena Pharmaceuticals, Inc.
ALNAQ · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $35 | $30 | $62 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $3 | $3 |
| Total Curr. Assets | $33 | $37 | $33 | $64 |
| Property Plant & Equip (Net) | $2 | $2 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $39 | $34 | $65 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $4 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $3 | $3 | $4 |
| Total Curr. Liab. | $16 | $6 | $11 | $6 |
| LT Debt | $0 | $10 | $6 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $10 | $6 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16 | $16 | $17 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$246 | -$198 | -$165 | -$118 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $265 | $220 | $183 | $167 |
| Total Equity | $19 | $23 | $17 | $49 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $39 | $34 | $65 |
| Net Debt | -$29 | -$25 | -$20 | -$52 |